Skip to content

Clinical Evaluation of Kanchanar Shunti Ghanvati in the Managementof Hypothyroidism

A Randomized Controlled Clinical Trial to Study Effect of Kanchnar Shunti Ghanvati and Thyroxine 25 MCG in patients of Primary Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100133
Enrollment
150
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Sponsors

Dr Mayuri Sunil Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)patient fullfilling the laboratory diagnosis of hypothyroidism on the basis of serum TSH ,T3 and T4 levels 2)patients having TSH level less than 10 mlU/l 3)patients having uncontrolled TSH level in spite of adequate doses of levothyroxine 4)patients having signs and symptoms of hypothyroidism .

Exclusion criteria

Exclusion criteria: 1) patiet with ischemic heart diasease ,uncontrolled hypertension,myocardial infraction,cerebrovascular event, cardiac arrthmias,pregnancy and active malignant diasease were excluded. 2)patient with altered thyroid harmone levels due to other conditions such as under nutrition,malignant neoplasm or nonthyroidal illness (low t3 syndrome) 3) patient havinh TSH level greater than 10 mlU/l 4) recent thyroid surgery within 12 months 5) patient suffering from diasease like HIV,TB,Encephalopathy,Goitre,other endocrine disorders, and other auto immune disorders.

Design outcomes

Primary

MeasureTime frame
1)to assess the changes in subjective and objective parameters of hypothyroidism with the effect of kanchnar shunthi vati after treatment. 2) to assess the changes in subjective and objective criteria assessment of objective parameters 1)TSH LEVELS 2)WeightTimepoint: Time period will be 1 year

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Popat Jagtap

Shree Saptashrungi Ayurved Mahavidyalay

drpvjagtap@gmail.com9822852144

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026